Separating primary from secondary changes in the autistic brain has long been a research goal. With knowledge of wide-ranging molecular deficits, identification of the best therapeutic targets becomes a priority. See Letter p.380
References
Geschwind, D. H. & Levitt, P. Curr. Opin. Neurobiol. 17, 103–111 (2007).
Voineagu, I. et al. Nature 474, 380–384 (2011).
Dennis, G. et al. Genome Biol. 4, P3 (2003).
Langfelder, P. & Horvath, S. BMC Bioinformatics 9, 559 (2008).
Judson, M. C., Eagleson, K. L. & Levitt, P. J. Neurodev. Disord. doi:10.1007/s11689-011-9081-8 (2011).
Garbett, K. et al. Neurobiol. Dis. 30, 303–311 (2008).
Martin, C. L. et al. Am. J. Med. Genet. B 144B, 869–876 (2007).
Wang, K. et al. Nature 459, 528–533 (2009).
Williams, N. M. et al. Lancet 376, 1401–1408 (2010).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Korade, Ž., Mirnics, K. The autism disconnect. Nature 474, 294–295 (2011). https://doi.org/10.1038/474294a
Published:
Issue Date:
DOI: https://doi.org/10.1038/474294a
- Springer Nature Limited